Generic Name and Formulations:
Patiromer 8.4g, 16.8g, 25.2g; per pkt; pwd for oral susp.
Indications for VELTASSA:
Limitations Of use:
Not for emergency treatment for life-threatening hyperkalemia due to its delayed onset of action.
Give at least 3hrs before or 3hrs after other oral medications. Take with food. Initially 8.4g once daily. Adjust dose in 8.4g increments as needed at ≥1-week intervals to obtain desired serum potassium target range; max 25.2g/day.
Monitor serum potassium, magnesium. Consider magnesium supplementation if low serum levels develop. Severe constipation, bowel obstruction or impaction, abnormal post-op bowel motility disorders; avoid.
May reduce absorption and efficacy of other oral medications; separate dosing by at least 3hrs.
Constipation, hypomagnesemia, diarrhea, nausea, abdominal discomfort, flatulence.
Single-use packets (8.4g)—4, 30; (16.8g, 25.2g)—30
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)